EMA recommends Moderna's new Omicron-tailored vaccine
reuters.com
news
2022-10-19 15:28:02

Moderna logo and stock graph are seen displayed in this illustration taken, May 3, 2022. REUTERS/Dado Ruvic/Illustration/File PhotoOct 19 (Reuters) - The European Medical Agency on Wednesday recommended authorization of Moderna Inc's (MRNA.O) COVID-19 vaccine tailored towards targeting the Omicron sub-variants BA.4 and BA.5 for 12 and above ages.The European Commission has already approved Moderna's vaccine targeting Omicron BA.1 last month.Register now for FREE unlimited access to Reuters.comReporting by Khushi Mandowara; Editing by Maju SamuelOur Standards: The Thomson Reuters Trust Principles.
